Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767234 · ClinicalTrials.gov registry record
Permission to Collect Blood Over Time for Research
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 104
- Enrollment target
NCT00767234: Clinical Trial study, sponsored by Stanford University.
NCT00767234 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767234 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 104 participants
- Enrollment target
Study Summary
To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.
Interventions
- PROCEDURE Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767234
The ClinicalTrials.gov registry entry for NCT00767234 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT00767234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767234 about?
NCT00767234 is a clinical study titled "Permission to Collect Blood Over Time for Research". To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of ind...
What is the current status of trial NCT00767234?
This trial is currently terminated. The enrollment target is 104 participants. The study started on 2008-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00767234?
The interventions under investigation include: Observation (PROCEDURE).
Who is sponsoring clinical trial NCT00767234?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.